Published in J Arthroplasty on April 10, 2008
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement (SPACERHIP) | NCT01373099
Clinical practice. Infection associated with prosthetic joints. N Engl J Med (2009) 4.26
Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res (2009) 2.45
Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res (2014) 2.11
Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop (2012) 2.05
Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res (2013) 1.74
Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis (2014) 1.65
Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop (2009) 1.64
No infection reduction using chlorhexidine wipes in total joint arthroplasty. Clin Orthop Relat Res (2013) 1.54
The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res (2011) 1.54
A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One (2010) 1.52
Compliance with Surgical Care Improvement Project measures and hospital-associated infections following hip arthroplasty. J Bone Joint Surg Am (2012) 1.50
Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res (2010) 1.50
Do claims-based comorbidities adequately capture case mix for surgical site infections? Clin Orthop Relat Res (2014) 1.45
Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis. Clin Epidemiol (2012) 1.41
What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients. BMC Med (2012) 1.36
The Chitranjan Ranawat Award: fate of two-stage reimplantation after failed irrigation and débridement for periprosthetic knee infection. Clin Orthop Relat Res (2011) 1.35
Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study. J Orthop Res (2011) 1.34
What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat Res (2010) 1.29
Current concepts for clean air and total joint arthroplasty: laminar airflow and ultraviolet radiation: a systematic review. Clin Orthop Relat Res (2011) 1.28
Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections. Clin Orthop Relat Res (2010) 1.18
Assessing the gold standard: a review of 253 two-stage revisions for infected TKA. Clin Orthop Relat Res (2012) 1.15
Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers. Acta Orthop (2011) 1.14
Improved results of primary total hip replacement. Acta Orthop (2010) 1.13
The "true" incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop (2015) 1.12
A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord (2013) 1.11
Protective role of IL-1β against post-arthroplasty Staphylococcus aureus infection. J Orthop Res (2011) 1.08
Advance pre-operative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop (2010) 1.08
Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop (2011) 1.08
Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty. Int Orthop (2010) 1.05
Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty? Clin Orthop Relat Res (2015) 1.02
Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment. Clin Orthop Relat Res (2013) 1.01
Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J Clin Microbiol (2009) 1.01
Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect Immun (2014) 1.00
Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents (2013) 0.99
Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients. Acta Orthop (2013) 0.99
Do serologic and synovial tests help diagnose infection in revision hip arthroplasty with metal-on-metal bearings or corrosion? Clin Orthop Relat Res (2015) 0.99
Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA. Clin Orthop Relat Res (2014) 0.98
Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis. J Orthop Res (2009) 0.96
Has the rate of in-hospital infections after total joint arthroplasty decreased? Clin Orthop Relat Res (2013) 0.96
Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years. Acta Orthop (2012) 0.95
Antibiotic-loaded cement in orthopedic surgery: a review. ISRN Orthop (2011) 0.95
Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res (2013) 0.94
Re-Infection Outcomes Following One- And Two-Stage Surgical Revision of Infected Knee Prosthesis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.93
2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop (2013) 0.93
Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice. Antimicrob Agents Chemother (2012) 0.93
Decreased bacteria activity on Si₃N₄ surfaces compared with PEEK or titanium. Int J Nanomedicine (2012) 0.93
Periprosthetic joint infection: Current concept. Indian J Orthop (2013) 0.93
Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection. Antimicrob Agents Chemother (2013) 0.93
Minimizing dynamic knee spacer complications in infected revision arthroplasty. Clin Orthop Relat Res (2012) 0.93
A systematic review of animal models for Staphylococcus aureus osteomyelitis. Eur Cell Mater (2014) 0.92
Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin Orthop Relat Res (2010) 0.92
IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection. J Immunol (2015) 0.92
Preoperative waiting time increased the risk of periprosthetic infection in patients with femoral neck fracture. Acta Orthop (2013) 0.91
Culture-negative periprosthetic joint infection does not preclude infection control. Clin Orthop Relat Res (2012) 0.90
Periprosthetic joint infections at a teaching hospital in 1990-2007. Can J Surg (2012) 0.89
Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J Orthop Res (2014) 0.89
Electrospun vancomycin-loaded coating on titanium implants for the prevention of implant-associated infections. Int J Nanomedicine (2014) 0.88
Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin. Antimicrob Agents Chemother (2015) 0.87
Future patient demand for shoulder arthroplasty by younger patients: national projections. Clin Orthop Relat Res (2015) 0.86
Diagnostic work-up strategy for periprosthetic joint infections after total hip and knee arthroplasty: a 12-year experience on 320 consecutive cases. Patient Saf Surg (2015) 0.85
A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis. Clin Orthop Relat Res (2015) 0.85
Anti-Glucosaminidase Monoclonal Antibodies as a Passive Immunization for Methicillin-Resistant Staphylococcus aureus (MRSA) Orthopaedic Infections. Bonekey Osteovision (2011) 0.84
UPDATE ON INFECTIONS IN ARTICULAR PROSTHESIS. Rev Bras Ortop (2015) 0.83
Periprosthetic joint infections. Interdiscip Perspect Infect Dis (2013) 0.83
Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies. Int J Nanomedicine (2013) 0.83
Infection rates following hip and knee joint arthroplasty: large referral centre versus a small elective-only hospital. Eur J Orthop Surg Traumatol (2012) 0.83
In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis. J Pharm Sci (2013) 0.83
Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures. Eur J Clin Microbiol Infect Dis (2014) 0.82
Two-Stage Revision TKA Is Associated with High Complication and Failure Rates. Adv Orthop (2014) 0.82
A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes. Infect Immun (2015) 0.82
Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. CMAJ Open (2015) 0.82
Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes. Pharm Res (2012) 0.82
Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection. Int Orthop (2014) 0.82
Low rate of infection control in enterococcal periprosthetic joint infections. Clin Orthop Relat Res (2012) 0.81
Assessing the value of a total joint replacement. Curr Rev Musculoskelet Med (2012) 0.81
Antibacterial efficacy of ultrahigh molecular weight polyethylene with silver containing diamond-like surface layers. AMB Express (2015) 0.81
Identification and preoperative optimization of risk factors to prevent periprosthetic joint infection. World J Orthop (2014) 0.81
Do dynamic cement-on-cement knee spacers provide better function and activity during two-stage exchange? Clin Orthop Relat Res (2012) 0.81
A model of implant-associated infection in the tibial metaphysis of rats. ScientificWorldJournal (2013) 0.80
Diabetic mouse model of orthopaedic implant-related Staphylococcus aureus infection. PLoS One (2013) 0.80
Systematic Review and Meta-analysis of Randomized Controlled Trials of Antibiotics and Antiseptics for Preventing Infection in People Receiving Primary Total Hip and Knee Prostheses. Antimicrob Agents Chemother (2015) 0.79
Hypertensive patients show delayed wound healing following total hip arthroplasty. PLoS One (2011) 0.79
Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost. J Clin Orthop Trauma (2015) 0.79
Infectious Dose Dictates the Host Response during Staphylococcus aureus Orthopedic-Implant Biofilm Infection. Infect Immun (2016) 0.78
Chronic periprosthetic hip infection: micro-organisms responsible for infection and re-infection. Int Orthop (2016) 0.78
Antibacterial efficacy of titanium-containing alloy with silver-nanoparticles enriched diamond-like carbon coatings. AMB Express (2015) 0.78
Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infections. Open Orthop J (2013) 0.78
Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty. PLoS One (2014) 0.77
Delivery of antibiotics from cementless titanium-alloy cubes may be a novel way to control postoperative infections. Biomed Res Int (2015) 0.77
Challenges and barriers to improving care of the musculoskeletal patient of the future - a debate article and global perspective. Patient Saf Surg (2011) 0.77
XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways. Infect Immun (2016) 0.77
Editorial: Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well? Arthritis Rheumatol (2014) 0.77
Antimicrobial effects of nanofiber poly(caprolactone) tissue scaffolds releasing rifampicin. J Mater Sci Mater Med (2012) 0.76
Increased release time of antibiotics from bone allografts through a novel biodegradable coating. Biomed Res Int (2014) 0.76
MR Imaging of Knee Arthroplasty Implants. Radiographics (2015) 0.76
A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model. PLoS One (2015) 0.76
Detectable serum tobramycin levels in patients with renal dysfunction and recent placement of antibiotic-impregnated cement knee or hip spacers. Clin Infect Dis (2014) 0.76
Release of Cu2+ from a copper-filled TiO2 coating in a rabbit model for total knee arthroplasty. J Mater Sci Mater Med (2013) 0.76
Irrigation and Debridement Before a 2-Stage Revision Total Knee Arthroplasty Does Not Increase Risk of Failure. J Arthroplasty (2015) 0.75
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18
Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res (2003) 12.86
Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am (2005) 7.56
The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am (2009) 5.33
Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res (2008) 5.05
Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res (2009) 4.49
Economic burden of periprosthetic joint infection in the United States. J Arthroplasty (2012) 4.01
The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res (2009) 3.94
Anterior femoroacetabular impingement: part II. Midterm results of surgical treatment. Clin Orthop Relat Res (2004) 3.93
Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 3.78
Anterior femoroacetabular impingement: part I. Techniques of joint preserving surgery. Clin Orthop Relat Res (2004) 3.46
Diagnosis of periprosthetic infection. J Bone Joint Surg Am (2006) 3.04
International consensus on periprosthetic joint infection: description of the consensus process. Clin Orthop Relat Res (2013) 2.93
Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am (2008) 2.74
16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol (2011) 2.47
Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res (2009) 2.45
Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty (2009) 2.40
The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J Bone Joint Surg Am (2009) 2.28
Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976) (2010) 2.24
Operating room traffic is a major concern during total joint arthroplasty. Clin Orthop Relat Res (2012) 2.18
The direct and indirect costs to society of treatment for end-stage knee osteoarthritis. J Bone Joint Surg Am (2013) 2.12
Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res (2014) 2.11
Prospective randomized study of two surgical approaches for total hip arthroplasty. J Arthroplasty (2010) 2.03
Criteria used by medical students to rank orthopedic surgery residency programs. Am J Orthop (Belle Mead NJ) (2006) 2.01
The role of patient restrictions in reducing the prevalence of early dislocation following total hip arthroplasty. A randomized, prospective study. J Bone Joint Surg Am (2005) 1.95
Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am (2007) 1.89
Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg (2010) 1.85
Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am (2008) 1.80
Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am (2012) 1.76
In hospital complications after total joint arthroplasty. J Arthroplasty (2008) 1.69
Chemical contribution to surface-enhanced Raman scattering. Phys Rev Lett (2006) 1.63
International survey of primary and revision total knee replacement. Int Orthop (2011) 1.60
The 2012 Chitranjan Ranawat award: intraarticular analgesia after TKA reduces pain: a randomized, double-blinded, placebo-controlled, prospective study. Clin Orthop Relat Res (2013) 1.58
The value of intraoperative Gram stain in revision total knee arthroplasty. J Bone Joint Surg Am (2009) 1.58
American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am (2011) 1.57
Total hip arthroplasties: what are the reasons for revision? Int Orthop (2007) 1.55
The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res (2011) 1.54
The noisy ceramic hip: is component malpositioning the cause? J Arthroplasty (2008) 1.53
The natural progression of synovial fluid white blood-cell counts and the percentage of polymorphonuclear cells after primary total knee arthroplasty: a multicenter study. J Bone Joint Surg Am (2013) 1.53
Failure following revision total knee arthroplasty: infection is the major cause. Int Orthop (2010) 1.53
Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. Nat Commun (2013) 1.50
Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res (2010) 1.50
Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg (2010) 1.50
Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res (2011) 1.48
Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty (2010) 1.47
Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res (2012) 1.46
The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty (2009) 1.44
Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol (2010) 1.44
Do ceramic femoral heads reduce taper fretting corrosion in hip arthroplasty? A retrieval study. Clin Orthop Relat Res (2013) 1.44
Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res (2012) 1.44
The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res (2015) 1.42
Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol (2012) 1.41
A systematic review of all-ceramic crowns: clinical fracture rates in relation to restored tooth type. Int J Prosthodont (2012) 1.40
A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J Virol (2009) 1.38
Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am (2009) 1.38
A simple, cost-effective screening protocol to rule out periprosthetic infection. J Arthroplasty (2008) 1.38
The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest (2003) 1.38
Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res (2010) 1.37
Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty (2011) 1.37
Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res (2007) 1.35
Demographic factors affecting long-term outcome of total hip arthroplasty. Clin Orthop Relat Res (2003) 1.35
Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop Relat Res (2010) 1.35
The use of a constrained acetabular component to treat instability after total hip arthroplasty. J Bone Joint Surg Am (2003) 1.34
The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis (2009) 1.34
Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res (2009) 1.34
American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am (2009) 1.34
Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection. J Bone Joint Surg Am (2012) 1.34
Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population. J Bone Miner Res (2011) 1.32
Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am (2013) 1.32
Total knee arthroplasty survivorship in the United States Medicare population: effect of hospital and surgeon procedure volume. J Arthroplasty (2008) 1.30
US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev (2008) 1.30
Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res (2010) 1.28
Primary and revision arthroplasty surgery caseloads in the United States from 1990 to 2004. J Arthroplasty (2008) 1.26
Infection control rate of irrigation and débridement for periprosthetic joint infection. Clin Orthop Relat Res (2011) 1.26
Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg (2009) 1.25
Impact of socioeconomic factors on outcome of total knee arthroplasty. Clin Orthop Relat Res (2014) 1.24
Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One (2012) 1.24
The Chitranjan Ranawat Award: Should prophylactic antibiotics be withheld before revision surgery to obtain appropriate cultures? Clin Orthop Relat Res (2014) 1.23
Early mortality after modern total hip arthroplasty. Clin Orthop Relat Res (2008) 1.23
2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res (2006) 1.23
Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS One (2013) 1.22
Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty (2011) 1.22
The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials (2008) 1.21
Periprosthetic infection: where do we stand with regard to Gram stain? Acta Orthop (2009) 1.21
Perioperative antibiotics should not be withheld in proven cases of periprosthetic infection. Clin Orthop Relat Res (2007) 1.21
Rotating hinged total knee replacement: use with caution. J Bone Joint Surg Am (2007) 1.19
Renal impairment following total joint arthroplasty: who is at risk? J Arthroplasty (2010) 1.18